Purpose: To evaluate the feasibility of femtosecond laser-assisted (FA) tunnel creation as a pretreatment for creating a big bubble (BB) to pneumo-dissect the corneal stroma from Descemet membrane.
Methods: Five human cadaver eyes received pretreatment using a femtosecond laser. An intrastromal tunnel, along with a side cut, was achieved using customized femtosecond corneal disruption (custom mask). Before treatment, optical coherence tomography was performed and the intrastromal tunnel was intended to achieve a parallel orientation with respect to the corneal endothelial cell layer (50 µm above the endothelium). Surgical dissection of the side cut using a Sinskey hook was performed, followed by insertion of a deep anterior lamellar keratoplasty cannula into the tunnel and pneumo-dissection (BB). All corneas after treatment were prepared for histologic evaluation (light microscopy).
Results: FA pretreatment was successful in all 5 cadaveric corneas, and the BB was achieved in all eyes as well. Histologic evaluation of the corneas revealed complete separation of Descemet membrane and stroma in all eyes, with no remaining stroma attached to Descemet membrane and no signs of perforation.
Conclusions: FABB seems feasible because pneumo-dissection of the corneal stroma from Descemet membrane was achieved in all human cadaver corneas of this experimental study. Optical coherence tomography, corneal histology, and macroscopic evaluation revealed complete Descemet-stromal separation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/ICO.0000000000001004 | DOI Listing |
Cornea
January 2025
Department of Ophthalmology and Visual Sciences, Case Western Reserve University School of Medicine, University Hospitals Eye Institute, Cleveland, OH.
Purpose: Describe aims, methods, characteristics of donors, donor corneas and recipients, and potential impact of the Diabetes Endothelial Keratoplasty Study (DEKS).
Methods: The DEKS is a randomized, clinical trial to assess graft success and endothelial cell density (ECD) 1 year after Descemet membrane endothelial keratoplasty (DMEK) using corneas from donors with versus without diabetes in a 1:2 minimization assignment. Diabetes severity in the donor is assessed by medical history, postmortem HbA1c, and donor skin advanced glycation end-products and oxidation markers.
Cornea
January 2025
Eye Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Klin Monbl Augenheilkd
January 2025
Ophthalmology, Amsterdam UMC, Amsterdam, Netherlands.
Background: Refractory corneal edema is the foremost reason for endothelial corneal transplantation (EK) in the world. Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK) offer good clinical outcomes. However, human donor tissue is limited in availability and has a complex logistical chain.
View Article and Find Full Text PDFJ Fr Ophtalmol
January 2025
Centrum Medyczne "Julianów", 91-321 Łódź, ul. Żeglarska, Poland.
J Fr Ophtalmol
January 2025
Service d'ophtalmologie, hôpital La Timone, 264, rue Saint-Pierre, 13005 Marseille, France.
Purpose: To analyze the outcomes and frequency of complications after Descemet's membrane endothelial keratoplasty (DMEK) and evaluate the parameters associated with the occurrence of these complications.
Methods: A multicenter retrospective study of 143 DMEK procedures performed consecutively by five surgeons between June 2018 and March 2021 was performed. Surgeon-specific surgical and graft characteristics were also assessed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!